NNVC: nanoviricides.com Cash Funds per Share

Corporate emblem and logo of NanoViricides (NNVC)

NanoViricides, Inc. (NNVC) is striving for global dominance in the antiviral sector by scaling its nanotechnology. Cash per share demonstrates conservative resilience, with the metric holding at 0.10. International alliances for the treatment of influenza and herpes support the company, although the lack of current sales and R&D expenses are already priced in.

nanoviricides.com (NNVC) Cash Funds per Share: for the period 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for nanoviricides.com (NNVC)

- market price and analyst price targets:
- market capitalization information:
- cash position and cash flow details:
Summary company analysis:NanoViricides, Inc.
Manufactured product of NanoViricides, Inc.

NanoViricides, Inc. (NNVC) develops proprietary nanotechnology virus traps, which requires significant R&D capital. The metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. This metric determines the portion of actual cash allocated to each security. It serves as an indicator of the company's financial stability and margin of safety. By analyzing cash per share trends, an investor assesses the business's ability to fund innovation without external borrowing.